UPDATE: Goldman Sachs Initiates Aviv REIT with Neutral on Notable Stock Appreciation

In a report published Monday, Goldman Sachs analyst Andrew Rosivach initiated coverage on Aviv REIT

with a Neutral rating and $25.00 price target. In the report, Rosivach noted, “We initiate coverage of Aviv REIT (AVIV) with a Neutral rating and a 12-month price target of $25 (6% total return including dividends). Aviv's experienced management team has the capital structure in place to acquire assets in the fragmented skilled nursing facility (SNF) space. However, we believe the stock's notable 25% appreciation since its IPO will require a similar track record of consistent earnings growth in the public markets as peers for the share price to continue to perform.” Aviv REIT closed on Friday at $24.42.